Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 15.5b

Steroid Avoidance Rate at Discharge, 2000 to 2009

Recipients of Living Donor Livers

Discharge Regimen Year of Transplant
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Total Patients 332 453 308 282 292 289 260 244 227 197
Steroids Avoided 30 40 25 63 64 69 73 71 47 40
Rate 9.0% 8.8% 8.1% 22.3% 21.9% 23.9% 28.1% 29.1% 20.7% 20.3%
CyA Patients 19 16 6 9 - 1 1 1 1 -
Steroids Avoided 1 8 1 1 - 0 0 1 1 -
Rate 5.3% 50.0% 16.7% 11.1% - 0.0% 0.0% 100.0% 100.0% -
Tac Patients 126 156 123 101 105 103 105 75 53 65
Steroids Avoided 7 11 18 27 35 36 31 12 4 9
Rate 5.6% 7.1% 14.6% 26.7% 33.3% 35.0% 29.5% 16.0% 7.5% 13.8%
CyA+MMF Patients 18 24 22 18 18 9 4 7 6 4
Steroids Avoided 0 0 2 2 1 2 2 2 1 0
Rate 0.0% 0.0% 9.1% 11.1% 5.6% 22.2% 50.0% 28.6% 16.7% 0.0%
Tac+MMF Patients 113 174 118 136 142 152 142 142 158 118
Steroids Avoided 5 2 3 28 24 23 39 51 41 29
Rate 4.4% 1.1% 2.5% 20.6% 16.9% 15.1% 27.5% 35.9% 25.9% 24.6%
CyA+Aza Patients 3 2 4 3 2 2 - 3 1 -
Steroids Avoided 0 0 0 1 0 0 - 0 0 -
Rate 0.0% 0.0% 0.0% 33.3% 0.0% 0.0% - 0.0% 0.0% -
Tac+Aza Patients 2 - 3 - - 1 - 2 1 -
Steroids Avoided 0 - 0 - - 1 - 1 0 -
Rate 0.0% - 0.0% - - 100.0% - 50.0% 0.0% -
CyA+Siro Patients 7 6 2 - 1 - - - - -
Steroids Avoided 4 3 0 - 0 - - - - -
Rate 57.1% 50.0% 0.0% - 0.0% - - - - -
Tac+Siro Patients 20 36 11 1 5 1 2 3 - -
Steroids Avoided 8 11 0 0 1 0 0 0 - -
Rate 40.0% 30.6% 0.0% 0.0% 20.0% 0.0% 0.0% 0.0% - -
Siro+MMF Patients 1 5 2 1 1 1 - 2 - -
Steroids Avoided 0 0 0 0 0 0 - 0 - -
Rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% - 0.0% - -
Other Regimen Patients 23 34 17 13 18 19 6 9 7 10
Steroids Avoided 5 5 1 4 3 7 1 4 0 2
Rate 21.7% 14.7% 5.9% 30.8% 16.7% 36.8% 16.7% 44.4% 0.0% 20.0%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressive

drug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine;

Siro: Sirolimus.